{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:50:40Z","timestamp":1784094640098,"version":"3.55.0"},"reference-count":100,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>West Nile virus is an arbovirus primarily spread by mosquitoes, which are the principal carriers and belong to the Flaviviridae category. This widespread disease lacks specific treatments despite its potential lethality, urgently demanding novel pharmaceutical research and development aims to prevent severe or long-term complications and improve overall outcomes. Pandemic awareness, increasing global incidence, fatal illness effects, expenses associated with outbreaks, reducing suffering, and other broader implications highlight the study\u2019s wider significance. Drug design as a novel treatment approach to reduce the risk of resistance to the virus resulting from overuse of broad-spectrum antiviral therapies for unrelated viral diseases has been evaluated using computational techniques. Initially, molecular docking targeted the envelope glycoprotein of the WNV, utilizing a set of 5375 phytochemicals found in the IMPPAT database. Their binding affinities were \u22127.464, \u22125.802, \u22125.617, and \u22124.92, kcal\/mol for CID: 359 (Phloroglucinol), 9064 (Cianidanol), 25310 (L-Rhamnose), and 492405 (Favipiravir), respectively. The lead compounds and the control ligand both bind at the common active site of the\u00a0macro-molecule, as evidenced by their interactions with the same amino acid residues at LEU281, ASN47, THR282, SER29, MET48, MET46, and MET45, correspondingly. In post-docking MM-GBSA the negative binding energy of the P-L complex for the compounds CIDs: 359, 9064, 25310, and 492405 (control) were \u221229.16, \u221233.45, \u221232.02, and \u22123.16 kcal\/mol, correspondingly. The selected compounds are secure and efficient since they demonstrate excellent toxicological and Pk characteristics. The compounds were further evaluated to confirm their stability and binding affinity to the target protein by molecular dynamics simulation (RMSD, RMSF, Rg, SASA, H-bond, P-L, and L-P contact). Following this, principal component analysis (PCA) and dynamic cross-correlation matrix (DCCM) studies were conducted using the MD trajectory data. The ligands evaluated in this study demonstrated considerable stability of the proteins\u2019 binding site when complexed with CID: 9064 and CID: 25310, respectively, in the MD simulation, which also revealed a high negative binding free energy value, indicating a robust interaction between the target and lead compounds. The three principal components (PC1, PC2, PC3) for the lead compounds corresponding to CID: 9064 (40.37%, 23.02%, and 8.82%) and CID: 25310 (73.04%, 10.06%, and 3.77%), respectively, indicate that their complexes are more stable than the other L-P complexes. Consequently, both the compounds derived from the plants <jats:italic>Tamarindus indica<\/jats:italic> and <jats:italic>Plantago ovate<\/jats:italic>, respectively, may potentially impede the viral activity of the WNV envelope glycoprotein, indicating the possibility of these compounds as prospective phytochemical therapeutic candidates. This preclinical study can be used in further drug development processes, including <jats:italic>in vivo<\/jats:italic> studies and animal trials.<\/jats:p>","DOI":"10.1371\/journal.pone.0321902","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:50:09Z","timestamp":1745517009000},"page":"e0321902","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular activity of bioactive phytocompounds for inhibiting host cell attachment and membrane fusion interacting with West Nile Virus envelope glycoprotein"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-6653","authenticated-orcid":true,"given":"Noimul Hasan","family":"Siddiquee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9020-9989","authenticated-orcid":true,"given":"Shanjida Akter","family":"Joyoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra Binte","family":"Zaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansura Akter","family":"Eva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alif Islam","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat Jahan","family":"Mridu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Amin","family":"Shawon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjida","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnuva Jamil","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita Sarkar","family":"Katha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rafiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-9740","authenticated-orcid":true,"given":"Mohammad Sharif","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"3","key":"pone.0321902.ref001","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/jama.2013.8042","article-title":"West Nile virus: review of the literature","volume":"310","author":"LR Petersen","year":"2013","journal-title":"JAMA"},{"issue":"43","key":"pone.0321902.ref002","doi-asserted-by":"crossref","first-page":"20613","DOI":"10.2807\/1560-7917.ES2013.18.43.20613","article-title":"Outbreak of West Nile virus infection among humans in Serbia, August to October 2012","volume":"18","author":"N Popovi\u0107","year":"2013","journal-title":"Euro Surveill"},{"issue":"10","key":"pone.0321902.ref003","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/v5102384","article-title":"Vaccines in development against West Nile virus","volume":"5","author":"S Brandler","year":"2013","journal-title":"Viruses"},{"issue":"4","key":"pone.0321902.ref004","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jama.290.4.524","article-title":"West Nile virus","volume":"290","author":"LR Petersen","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"pone.0321902.ref005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.saep.2004.01.002","article-title":"West Nile virus","volume":"13","author":"DN Phalen","year":"2004","journal-title":"Semin Avian Exot Pet Med"},{"issue":"4","key":"pone.0321902.ref006","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00705-004-0463-z","article-title":"West Nile virus in the vertebrate world","volume":"150","author":"KM van der Meulen","year":"2005","journal-title":"Arch Virol"},{"key":"pone.0321902.ref007","first-page":"309","article-title":"The role of birds in the ecology of West Nile virus in Europe and Africa","volume":"267","author":"M Malkinson","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"pone.0321902.ref008","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.02042-09","article-title":"Interplay of RNA elements in the dengue virus 5\u2019 and 3\u2019 ends required for viral RNA replication","volume":"84","author":"P Friebe","year":"2010","journal-title":"J Virol"},{"issue":"14","key":"pone.0321902.ref009","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"AA Khromykh","year":"2001","journal-title":"J Virol"},{"issue":"13","key":"pone.0321902.ref010","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1021\/bi952398v","article-title":"Evidence for the existence of a pseudoknot structure at the 3\u2019 terminus of the flavivirus genomic RNA","volume":"35","author":"PY Shi","year":"1996","journal-title":"Biochemistry"},{"issue":"3","key":"pone.0321902.ref011","article-title":"Unveiling the antiviral activity of 2\u2032,3,5,7-Tetrahydroxyflavanone as potential inhibitor of chikungunya virus envelope glycoprotein","volume":"47","author":"NH Siddiquee","year":"2024","journal-title":"Informatics Med Unlocked"},{"issue":"22","key":"pone.0321902.ref012","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"M Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"issue":"15","key":"pone.0321902.ref013","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.78.15.8271-8280.2004","article-title":"Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses","volume":"78","author":"E Lee","year":"2004","journal-title":"J Virol"},{"issue":"7","key":"pone.0321902.ref014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.embor.embor866","article-title":"Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses","volume":"4","author":"E Navarro-Sanchez","year":"2003","journal-title":"EMBO Rep"},{"issue":"52","key":"pone.0321902.ref015","doi-asserted-by":"crossref","first-page":"54533","DOI":"10.1074\/jbc.M410208200","article-title":"Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells","volume":"279","author":"JJH Chu","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0321902.ref016","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1074\/jbc.M506614200","article-title":"Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin","volume":"281","author":"JWM Lee","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0321902.ref017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/lt.20350","article-title":"Transmission of West Nile virus by organ transplantation","volume":"11","author":"S Kusne","year":"2005","journal-title":"Liver Transplant"},{"issue":"3415","key":"pone.0321902.ref018","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1126\/science.131.3415.1730","article-title":"Effects of absence of saliva on blood feeding by mosquitoes","volume":"131","author":"A Hudson","year":"1960","journal-title":"Science"},{"issue":"1","key":"pone.0321902.ref019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0014-4894(85)80029-1","article-title":"Aedes aegypti: model for blood finding strategy and prediction of parasite manipulation","volume":"60","author":"JMC Ribeiro","year":"1985","journal-title":"Exp Parasitol"},{"key":"pone.0321902.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jeb.108.1.1","article-title":"Role of mosquito saliva in blood vessel location","volume":"108","author":"JM Ribeiro","year":"1984","journal-title":"J Exp Biol"},{"key":"pone.0321902.ref021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2164-8-6","article-title":"An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti","volume":"8","author":"JMC Ribeiro","year":"2007","journal-title":"BMC Genomics"},{"issue":"Pt 22","key":"pone.0321902.ref022","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1242\/jeb.204.22.3887","article-title":"Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus","volume":"204","author":"JMC Ribeiro","year":"2001","journal-title":"J Exp Biol"},{"issue":"1","key":"pone.0321902.ref023","first-page":"24","article-title":"Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine","volume":"22","author":"A Salamonsen","year":"2015","journal-title":"Forsch Komplementmed"},{"issue":"2","key":"pone.0321902.ref024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/MMBR.00049-13","article-title":"Virus world as an evolutionary network of viruses and capsidless selfish elements","volume":"78","author":"EV Koonin","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"pone.0321902.ref025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0041-0101(00)00154-9","article-title":"Plants as source of drugs","volume":"39","author":"SMK Rates","year":"2001","journal-title":"Toxicon"},{"issue":"8","key":"pone.0321902.ref026","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1469-0691.12211","article-title":"West Nile virus in Europe: Emergence, epidemiology, diagnosis, treatment, and prevention","volume":"19","author":"V Sambri","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"pone.0321902.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/376871","article-title":"Human immunoglobulin as a treatment for West Nile virus infection","volume":"188","author":"AG Agrawal","year":"2003","journal-title":"J Infect Dis"},{"issue":"10","key":"pone.0321902.ref028","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1080\/21645515.2019.1621149","article-title":"West Nile virus vaccines - Current situation and future directions","volume":"15","author":"S Ulbert","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"pone.0321902.ref029","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/imt.10.93","article-title":"Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus","volume":"3","author":"DW Beasley","year":"2011","journal-title":"Immunotherapy"},{"key":"pone.0321902.ref030","first-page":"1","article-title":"Mathematical modeling of infectious diseases West Nile virus: a narrative from bioinformatics and mathematical","author":"J Wu","year":"2015"},{"issue":"1","key":"pone.0321902.ref031","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1371\/journal.pntd.0000356","article-title":"Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking","volume":"3","author":"D Ekonomiuk","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0321902.ref032","doi-asserted-by":"crossref","first-page":"1189786","DOI":"10.3389\/fmicb.2023.1189786","article-title":"Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: An in silico strategy leveraging molecular docking and dynamics simulation","volume":"14","author":"S Akash","year":"2023","journal-title":"Front Microbiol"},{"issue":"6","key":"pone.0321902.ref033","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"K Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pone.0321902.ref034","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiz078","article-title":"Laboratory findings, compassionate use of favipiravir, and outcome in patients with ebola virus disease, guinea, 2015-a retrospective observational study","volume":"220","author":"R Kerber","year":"2019","journal-title":"J Infect Dis"},{"issue":"12","key":"pone.0321902.ref035","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1080\/07391102.2018.1506362","article-title":"Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors","volume":"37","author":"KO Sulaiman","year":"2019","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0321902.ref036","doi-asserted-by":"crossref","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","article-title":"In silico methods and tools for drug discovery","volume":"137","author":"B Shaker","year":"2021","journal-title":"Comput Biol Med"},{"issue":"2","key":"pone.0321902.ref037","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.drudis.2015.12.007","article-title":"In silico methods to address polypharmacology: Current status, applications and future perspectives","volume":"21","author":"A Lavecchia","year":"2016","journal-title":"Drug Discov Today"},{"key":"pone.0321902.ref038","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2024.1362456","article-title":"Integrative computational approaches for discovery and evaluation of lead compound for drug design","volume":"4","author":"U Naithani","year":"2024","journal-title":"Front Drug Discov"},{"key":"pone.0321902.ref039","first-page":"899","article-title":"Biological crystallography the protein data bank","volume":"58","author":"HM Berman","year":"2002","journal-title":"Acta Cryst"},{"issue":"3","key":"pone.0321902.ref040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"GM Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"pone.0321902.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2024.101522","article-title":"Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing","volume":"48","author":"NH Siddiquee","year":"2024","journal-title":"Informatics Med Unlocked"},{"issue":"3","key":"pone.0321902.ref042","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: extending force field coverage for drug-like small molecules","volume":"15","author":"K Roos","year":"2019","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"pone.0321902.ref043","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","article-title":"IMPPAT: A curated database of Indian medicinal plants, phytochemistry and therapeutics","volume":"8","author":"K Mohanraj","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0321902.ref044","doi-asserted-by":"crossref","first-page":"108048","DOI":"10.1016\/j.compbiolchem.2024.108048","article-title":"Unveiling potential repurposed drug candidates for Plasmodium falciparum through in silico evaluation: a synergy of structure-based approaches, structure prediction, and molecular dynamics simulations","volume":"110","author":"A Das","year":"2024","journal-title":"Comput Biol Chem"},{"issue":"1","key":"pone.0321902.ref045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12551-013-0130-2","article-title":"Receptor-ligand molecular docking","volume":"6","author":"IA Guedes","year":"2014","journal-title":"Biophys Rev"},{"issue":"1","key":"pone.0321902.ref046","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"E Harder","year":"2016","journal-title":"J Chem Theory Comput"},{"issue":"12 Pt 2","key":"pone.0321902.ref047","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/009127000004001211","article-title":"Pharmacokinetic\/pharmacodynamic modeling in drug research and development","volume":"40","author":"H Derendorf","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"pone.0321902.ref048","first-page":"1","volume-title":"Miracle-gro S, States U. Pharmacokinetics","author":"SA Saghir","year":"2018"},{"issue":"5","key":"pone.0321902.ref049","first-page":"2063","article-title":"SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq","volume":"8","author":"D Ranjith","year":"2019","journal-title":"J Pharmacogn Phytochem"},{"issue":"4","key":"pone.0321902.ref050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41573-022-00633-x","article-title":"The evolving role of investigative toxicology in the pharmaceutical industry","volume":"22","author":"F Pognan","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"pone.0321902.ref051","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"DEV Pires","year":"2015","journal-title":"J Med Chem"},{"key":"pone.0321902.ref052","article-title":"Antiviral activity, pharmacoinformatics, molecular docking, and dynamics studies of Azadirachta indica against Nipah virus by targeting envelope glycoprotein: emerging strategies for developing antiviral treatment","author":"O Saha","year":"2024","journal-title":"Bioinform Biol Insights"},{"key":"pone.0321902.ref053","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2024.101458","article-title":"In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: a promising approach for developing new antiviral therapeutics","volume":"45","author":"NH Siddiquee","year":"2024","journal-title":"Informatics Med Unlocked"},{"key":"pone.0321902.ref054","doi-asserted-by":"crossref","first-page":"9780198520","DOI":"10.1093\/acprof:oso\/9780198520979.003.0008","article-title":"MAD phasing.","volume-title":"Macromolecular crystallography:cConverging high-throughput methods","author":"H Murthy","year":"2007"},{"issue":"1","key":"pone.0321902.ref055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biotechadv.2011.08.003","article-title":"Advances and applications of binding affinity prediction methods in drug discovery","volume":"30","author":"MD Parenti","year":"2012","journal-title":"Biotechnol Adv"},{"issue":"8","key":"pone.0321902.ref056","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12033-023-00831-x","article-title":"Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA","volume":"66","author":"AM da Fonseca","year":"2024","journal-title":"Mol Biotechnol"},{"issue":"9","key":"pone.0321902.ref057","first-page":"3213","article-title":"A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2","volume":"39","author":"R Islam","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"pone.0321902.ref058","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1039\/b600518g","article-title":"Phloroglucinol compounds of natural origin","volume":"23","author":"I Pal Singh","year":"2006","journal-title":"Nat Prod Rep"},{"issue":"2","key":"pone.0321902.ref059","first-page":"404","volume":"24","author":"J Gayathri","year":"2022","journal-title":"J Univ Shanghai Sci Technol"},{"issue":"16","key":"pone.0321902.ref060","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1021\/acs.jafc.2c00532","article-title":"Phloroglucinol and its derivatives: Antimicrobial properties toward microbial pathogens","volume":"70","author":"F Khan","year":"2022","journal-title":"J Agric Food Chem"},{"issue":"6","key":"pone.0321902.ref061","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1007\/s10811-016-0851-2","article-title":"Structural characterization and comparative biomedical properties of phloroglucinol from Indian brown seaweeds","volume":"28","author":"R Karthik","year":"2016","journal-title":"J Appl Phycol"},{"issue":"4","key":"pone.0321902.ref062","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3892\/or.2014.3355","article-title":"Phloroglucinol induces apoptosis via apoptotic signaling pathways in HT-29 colon cancer cells","volume":"32","author":"MH Kang","year":"2014","journal-title":"Oncol Rep"},{"issue":"11","key":"pone.0321902.ref063","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fct.2005.05.013","article-title":"Isolation and structure elucidation of phenolic antioxidants from Tamarind (Tamarindus indica L.) seeds and pericarp","volume":"43","author":"Y Sudjaroen","year":"2005","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"pone.0321902.ref064","doi-asserted-by":"crossref","first-page":"14389","DOI":"10.53730\/ijhs.v6nS2.8780","article-title":"Dimocarpus longan phytocompounds possess anticancer activity by specifically targeting breast cancer biomarkers via computational biology tools","volume":"6","author":"A Elengoe","year":"2022","journal-title":"Int J Health Sci (Qassim)"},{"key":"pone.0321902.ref065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122144","article-title":"The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson\u2019s disease models","volume":"333","author":"E Rymbai","year":"2023","journal-title":"Life Sci"},{"issue":"4","key":"pone.0321902.ref066","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0028-1099927","article-title":"Phytochemical studies of Egyptian Plantago species. (Lipids)","volume":"16","author":"ZF Ahmed","year":"1968","journal-title":"Planta Med"},{"issue":"1","key":"pone.0321902.ref067","first-page":"1","article-title":"L-rhamnose and L-fucose suppress cancer growth in mice","volume":"6","author":"P Tomsik","year":"2011","journal-title":"Cent Eur J Biol"},{"key":"pone.0321902.ref068","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"K Shiraki","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"2","key":"pone.0321902.ref069","doi-asserted-by":"crossref","first-page":"16","DOI":"10.32607\/actanaturae.11652","article-title":"Favipiravir and its structural analogs: Antiviral activity and synthesis methods","volume":"14","author":"ID Konstantinova","year":"2022","journal-title":"Acta Naturae"},{"key":"pone.0321902.ref070","unstructured":"Talreja S. Drug review: Favipiravir drug review: Favipiravir. 2020 September."},{"issue":"5","key":"pone.0321902.ref071","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab098","article-title":"Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein","volume":"22","author":"F Ahammad","year":"2021","journal-title":"Brief Bioinform"},{"key":"pone.0321902.ref072","first-page":"1","article-title":"Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer","author":"EK Talukder"},{"key":"pone.0321902.ref073","doi-asserted-by":"crossref","first-page":"106892","DOI":"10.1016\/j.micpath.2024.106892","article-title":"Cheminformatics-based analysis identified (Z)-2-(2,5-dimethoxy benzylidene)-6-(2-(4-methoxyphenyl)-2-oxoethoxy) benzofuran-3(2H)-one as an inhibitor of marburg replication by interacting with NP","volume":"195","author":"NH Siddiquee","year":"2024","journal-title":"Microb Pathog"},{"key":"pone.0321902.ref074","doi-asserted-by":"crossref","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","article-title":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review","volume":"354","author":"S Ghahremanian","year":"2022","journal-title":"J Mol Liq"},{"issue":"P3","key":"pone.0321902.ref075","first-page":"139924","article-title":"Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer","volume":"1321","author":"E Kabir","year":"2025","journal-title":"J Mol Struct"},{"issue":"39","key":"pone.0321902.ref076","doi-asserted-by":"crossref","first-page":"23466","DOI":"10.1039\/D0RA03206A","article-title":"Thompson loop: Opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein","volume":"10","author":"AT Adewumi","year":"2020","journal-title":"RSC Adv"},{"issue":"62","key":"pone.0321902.ref077","doi-asserted-by":"crossref","first-page":"37707","DOI":"10.1039\/D0RA06379G","article-title":"Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study","volume":"10","author":"M Surti","year":"2020","journal-title":"RSC Adv"},{"issue":"12","key":"pone.0321902.ref078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0310802","article-title":"Nature\u2019s defense against emerging neurodegenerative threats: dynamic simulation, PCA, DCCM identified potential plant-based antiviral lead targeting borna disease virus nucleoprotein","volume":"19","author":"N Siddiquee","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"pone.0321902.ref079","first-page":"1","article-title":"Natural products in precision neurological disease (cryptococcal meningitis): structure-based phytochemical screening of glycyrrhiza glabra plant against cryptococcus neoformans farnesyltransferase (FTase)","volume":"1","author":"N Siddiquee","year":"2025","journal-title":"Chem Biodivers"},{"key":"pone.0321902.ref080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2021.709932","article-title":"Inhibition of gsk_3\u03b2 by iridoid glycosides of snowberry (symphoricarpos albus) effective in the treatment of alzheimer\u2019s disease using computational drug design methods","volume":"9","author":"M Eskandarzadeh","year":"2021","journal-title":"Front Chem"},{"issue":"1","key":"pone.0321902.ref081","first-page":"24","article-title":"It Is Important to compute intramolecular hydrogen bonding in drug design?","volume":"5","author":"JR Yunta","year":"2017","journal-title":"Am J Model Optim"},{"issue":"4","key":"pone.0321902.ref082","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00726-007-0015-4","article-title":"Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study","volume":"34","author":"SK Panigrahi","year":"2008","journal-title":"Amino Acids"},{"issue":"1","key":"pone.0321902.ref083","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"FADM Opo","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0321902.ref084","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/bib\/bbaa382","article-title":"Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro","volume":"22","author":"S Bharadwaj","year":"2021","journal-title":"Brief Bioinform"},{"key":"pone.0321902.ref085","first-page":"1","article-title":"A beginner\u2019s guide to molecular dynamics simulations and the identification of cross-correlation networks for enzyme engineering","author":"H Yu","year":"2020","journal-title":"Enzyme Eng. Evol"},{"issue":"3","key":"pone.0321902.ref086","first-page":"519","article-title":"Reviews West Nile virus","volume":"2","author":"GL Campbell","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"pone.0321902.ref087","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fchem.2018.00246","article-title":"An immunopharmacoinformatics approach in development of vaccine and drug candidates for west nile virus","volume":"6","author":"MU Hossain","year":"2018","journal-title":"Front Chem"},{"issue":"3","key":"pone.0321902.ref088","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17460441.2020.1714586","article-title":"New avenues for therapeutic discovery against West Nile virus","volume":"15","author":"A Sinigaglia","year":"2020","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"pone.0321902.ref089","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3390\/v5122977","article-title":"West Nile virus drug discovery","volume":"5","author":"SP Lim","year":"2013","journal-title":"Viruses"},{"key":"pone.0321902.ref090","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"LG Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"5","key":"pone.0321902.ref091","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/med.20067","article-title":"Combining docking and molecular dynamic simulations in drug design","volume":"26","author":"H Alonso","year":"2006","journal-title":"Med Res Rev"},{"issue":"5","key":"pone.0321902.ref092","first-page":"1","article-title":"Discovering anti-cancer drugs via computational methods","volume":"11","author":"W Cui","year":"2020","journal-title":"Front Pharmacol"},{"issue":"3","key":"pone.0321902.ref093","doi-asserted-by":"crossref","first-page":"e0275765","DOI":"10.1371\/journal.pone.0275765","article-title":"Identification of potential human pancreatic \u03b1-amylase inhibitors from natural products by molecular docking, MM\/GBSA calculations, MD simulations, and ADMET analysis","volume":"18","author":"S Basnet","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"pone.0321902.ref094","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"CA Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"pone.0321902.ref095","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"November","key":"pone.0321902.ref096","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2147\/DDDT.S427193","article-title":"An integrative approach to study the inhibition of Providencia vermicola FabD using C2-quaternary indolinones","volume":"17","author":"A Khataniar","year":"2023","journal-title":"Drug Design, Development and Therapy"},{"issue":"15","key":"pone.0321902.ref097","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1080\/07391102.2020.1787226","article-title":"Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: An in silico study","volume":"39","author":"S Krupanidhi","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"47","key":"pone.0321902.ref098","doi-asserted-by":"crossref","first-page":"29267","DOI":"10.1039\/D1RA05268C","article-title":"Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights","volume":"11","author":"D Elebeedy","year":"2021","journal-title":"RSC Adv"},{"issue":"8","key":"pone.0321902.ref099","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1080\/07391102.2020.1753579","article-title":"Computational discovery of plant-based inhibitors against human carbonic anhydrase IX and molecular dynamics simulation","volume":"39","author":"S Mahmud","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"36","key":"pone.0321902.ref100","doi-asserted-by":"crossref","first-page":"22129","DOI":"10.1039\/D2CP03446H","article-title":"Deciphering the binding mechanism of inhibitors of the SARS-CoV-2 main protease through multiple replica accelerated molecular dynamics simulations and free energy landscapes","volume":"24","author":"M Li","year":"2022","journal-title":"Phys Chem Chem Phys"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:50:30Z","timestamp":1745517030000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321902"}},"subtitle":[],"editor":[{"given":"Fentahun","family":"Adane Nigat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321902","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}